Published in Am J Pathol on December 03, 2011
Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease. Biol Psychiatry (2014) 1.54
Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol (2012) 0.97
Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease. Neurobiol Aging (2016) 0.78
Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiol Aging (2015) 0.78
Rac1b enhances cell survival through activation of the JNK2/c-JUN/Cyclin-D1 and AKT2/MCL1 pathways. Oncotarget (2016) 0.77
Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression. Neuroscience (2016) 0.75
Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients. Neurosci Lett (2015) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics (2003) 16.60
Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci (2001) 11.40
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science (2001) 6.17
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet (1976) 6.09
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Alzheimer's disease: a disorder of cortical cholinergic innervation. Science (1983) 4.40
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging (2003) 3.83
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J (1978) 3.59
Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience (1983) 3.26
Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol (1983) 3.19
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett (1995) 3.15
Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol (2006) 2.93
Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res (1997) 2.71
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene (2000) 2.71
DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci (2001) 2.60
The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem (1996) 2.41
Rac1 GTPase: a "Rac" of all trades. Cell Mol Life Sci (2009) 2.19
Rho GTPases, dendritic structure, and mental retardation. J Neurobiol (2005) 2.19
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci (1982) 2.17
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci (2003) 2.14
Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci (1998) 2.06
Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res (1979) 2.04
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol (1992) 1.95
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J (1994) 1.85
Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol (2002) 1.82
Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene (1999) 1.82
Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol (2004) 1.81
Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol (2000) 1.80
Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol (2007) 1.77
Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development (1999) 1.73
Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J Biol Chem (2003) 1.71
Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem (2006) 1.67
Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene (2004) 1.66
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother (2008) 1.63
Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol Psychiatry (2004) 1.62
Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol (1999) 1.55
Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. J Neurosci (2002) 1.49
Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry (2010) 1.49
Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet (2006) 1.33
Amplification of RNA transcripts using terminal continuation. Lab Invest (2004) 1.30
The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci U S A (1994) 1.28
Nerve growth factor: two receptors, multiple functions. Bioessays (1998) 1.27
TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J Comp Neurol (1994) 1.26
mRna expression analysis of tissue sections and single cells. J Neurosci (2001) 1.25
Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol (1999) 1.25
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem (2011) 1.22
Transgenic models of Alzheimer's disease: learning from animals. NeuroRx (2005) 1.21
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry (2002) 1.20
The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain (2007) 1.19
Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol (2002) 1.19
Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J Neurosci Res (1999) 1.19
Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes. Int J Alzheimers Dis (2010) 1.17
Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Arch Neurol (2007) 1.16
Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res (2004) 1.16
RNA amplification strategies for small sample populations. Methods (2005) 1.15
Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol (2000) 1.14
Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol (1989) 1.13
Regulation of synaptic Rac1 activity, long-term potentiation maintenance, and learning and memory by BCR and ABR Rac GTPase-activating proteins. J Neurosci (2010) 1.12
Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Am J Pathol (2011) 1.07
RHO GTPase signaling for axon extension: is prenylation important? Mol Neurobiol (2010) 1.05
Expression of Rac1b stimulates NF-kappaB-mediated cell survival and G1/S progression. Exp Cell Res (2005) 1.02
Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord (2003) 1.02
Terminal continuation (TC) RNA amplification without second strand synthesis. J Neurosci Methods (2008) 1.01
Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J Comp Neurol (1989) 1.01
Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J Comp Neurol (1989) 1.01
Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Ann Neurol (1992) 1.00
Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci (1980) 1.00
Rho proteins and the cellular mechanisms of mental retardation. Am J Med Genet (2000) 0.99
Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice. J Alzheimers Dis (2010) 0.98
Abeta1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J Cell Sci (2007) 0.97
Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 0.97
Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. J Comp Neurol (2003) 0.94
Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Ann Neurol (1986) 0.91
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis (2010) 0.88
Combined histochemical staining, RNA amplification, regional, and single cell cDNA analysis within the hippocampus. Lab Invest (2004) 0.86
Plasma membrane microdomains in aging and disease. Geriatr Gerontol Int (2010) 0.86
Alzheimer's disease and related dementias: selective involvement of specific neuronal systems. CRC Crit Rev Clin Neurobiol (1985) 0.86
Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Chem Neuroanat (2011) 0.86
Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol Aging (1989) 0.85
Neuronal membranes are key to the pathogenesis of Alzheimer's disease: the role of both raft and non-raft membrane domains. Curr Alzheimer Res (2011) 0.84
Purification and biochemical properties of Rac1, 2, 3 and the splice variant Rac1b. Methods Enzymol (2006) 0.83
Qualitative gene profiling: a novel tool in genomics and in pharmacogenomics that deciphers messenger RNA isoforms diversity. Pharmacogenomics (2000) 0.83
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding. Bioorg Med Chem Lett (2009) 0.81
Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression. Brain Struct Funct (2011) 0.80
Immunohistochemical analysis of the basal forebrain in Alzheimer's disease. Mol Chem Neuropathol (1992) 0.77
Center stage for NGF in peripheral (but not central) sensory neuron outgrowth. Neuron (2000) 0.76
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med (2007) 5.87
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet (2006) 4.61
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A (2005) 4.34
Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science (2011) 4.16
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med (2005) 3.46
The birth and death of microRNA genes in Drosophila. Nat Genet (2008) 3.22
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 3.15
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2005) 2.97
A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem (2002) 2.85
SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature (2013) 2.52
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2007) 2.43
Neurobiology of butyrylcholinesterase. Nat Rev Neurosci (2003) 2.41
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem (2005) 2.36
Magnetoacoustic tomography with magnetic induction (MAT-MI). Phys Med Biol (2005) 2.36
Tembusu virus in ducks, china. Emerg Infect Dis (2011) 2.30
Osteopontin-c is a selective marker of breast cancer. Int J Cancer (2008) 2.20
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci (2003) 2.14
The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol (2006) 2.00
GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol (2004) 1.98
Highly enantioselective cyanosilylation of aldehydes catalyzed by novel beta-amino alcohol-titanium complexes. J Org Chem (2004) 1.89
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest (2005) 1.88
Quadcopter control in three-dimensional space using a noninvasive motor imagery-based brain-computer interface. J Neural Eng (2013) 1.85
Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol (2002) 1.82
Imaging electrical impedance from acoustic measurements by means of magnetoacoustic tomography with magnetic induction (MAT-MI). IEEE Trans Biomed Eng (2007) 1.81
Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest (2002) 1.76
Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J Biol Chem (2008) 1.76
Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry. J Nucl Med (2007) 1.73
Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem (2003) 1.73
Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A (2009) 1.72
Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors. Cancer Res (2012) 1.71
Comparison of different cortical connectivity estimators for high-resolution EEG recordings. Hum Brain Mapp (2007) 1.71
DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J Biol Chem (2006) 1.68
Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem (2006) 1.67
The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet (2005) 1.66
The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol (2010) 1.66
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A (2013) 1.66
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother (2008) 1.63
Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol (2011) 1.61
Speciation of heavy metals in marine sediments from the East China Sea by ICP-MS with sequential extraction. Environ Int (2004) 1.60
1-[3-(2-Naphth-yl)-5-(3,4,5-trimethoxy-phen-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone. Acta Crystallogr Sect E Struct Rep Online (2008) 1.60
Continuous three-dimensional control of a virtual helicopter using a motor imagery based brain-computer interface. PLoS One (2011) 1.56
Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol (2006) 1.56
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain (2014) 1.54
Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol (2007) 1.53
Interictal spike analysis of high-density EEG in patients with partial epilepsy. Clin Neurophysiol (2010) 1.51
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat (2003) 1.50
Protein lysine acylation and cysteine succination by intermediates of energy metabolism. ACS Chem Biol (2012) 1.49
Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry (2010) 1.49
A Phantom Study of Magnetoacoustic Tomography with Magnetic Induction (MAT-MI) for Imaging Electrical Impedance of Biological Tissue. J Appl Phys (2006) 1.48
Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol (2004) 1.48
Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes. Chem Biol (2012) 1.47
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment. Ann Neurol (2007) 1.45
Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc Natl Acad Sci U S A (2010) 1.45
Graph analysis of epileptogenic networks in human partial epilepsy. Epilepsia (2010) 1.45
Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Brain Res Dev Brain Res (2003) 1.43
Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol (2004) 1.43
Noninvasive three-dimensional electrocardiographic imaging of ventricular activation sequence. Am J Physiol Heart Circ Physiol (2005) 1.43
Magnetoacoustic tomographic imaging of electrical impedance with magnetic induction. Appl Phys Lett (2007) 1.41
Ictal source analysis: localization and imaging of causal interactions in humans. Neuroimage (2006) 1.41
Estimation of number of independent brain electric sources from the scalp EEGs. IEEE Trans Biomed Eng (2006) 1.40
Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Mol Cell Biol (2005) 1.40
Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains. Mov Disord (2010) 1.39
Herpes simplex virus 1 infection activates the endoplasmic reticulum resident kinase PERK and mediates eIF-2alpha dephosphorylation by the gamma(1)34.5 protein. J Virol (2005) 1.38
Estimation of in vivo brain-to-skull conductivity ratio in humans. Appl Phys Lett (2006) 1.37
The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J Neuropathol Exp Neurol (2005) 1.35
Defecting or not defecting: how to "read" human behavior during cooperative games by EEG measurements. PLoS One (2010) 1.32
Noninvasive reconstruction of three-dimensional ventricular activation sequence from the inverse solution of distributed equivalent current density. IEEE Trans Med Imaging (2006) 1.32
Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol (2002) 1.32
Motor imagery classification by means of source analysis for brain-computer interface applications. J Neural Eng (2004) 1.32
Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology (2008) 1.32
Three-dimensional imaging-based radiobiological dosimetry. Semin Nucl Med (2008) 1.31
Negative covariation between task-related responses in alpha/beta-band activity and BOLD in human sensorimotor cortex: an EEG and fMRI study of motor imagery and movements. Neuroimage (2009) 1.31
Amplification of RNA transcripts using terminal continuation. Lab Invest (2004) 1.30
Identification of CSPα clients reveals a role in dynamin 1 regulation. Neuron (2012) 1.28
Estimation of electrical conductivity distribution within the human head from magnetic flux density measurement. Phys Med Biol (2005) 1.27
Nurr1 in Parkinson's disease and related disorders. J Comp Neurol (2006) 1.27
Cortical imaging of event-related (de)synchronization during online control of brain-computer interface using minimum-norm estimates in frequency domain. IEEE Trans Neural Syst Rehabil Eng (2008) 1.27
Signals that dictate nuclear, nucleolar, and cytoplasmic shuttling of the gamma(1)34.5 protein of herpes simplex virus type 1. J Virol (2002) 1.27
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain (2012) 1.26
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model. Neuro Oncol (2005) 1.26
Skeletal abnormalities in Pth-null mice are influenced by dietary calcium. Endocrinology (2003) 1.26
A wavelet-based time-frequency analysis approach for classification of motor imagery for brain-computer interface applications. J Neural Eng (2005) 1.26
Activation of autophagy by α-herpesviruses in myeloid cells is mediated by cytoplasmic viral DNA through a mechanism dependent on stimulator of IFN genes. J Immunol (2011) 1.26
Classifying EEG-based motor imagery tasks by means of time-frequency synthesized spatial patterns. Clin Neurophysiol (2004) 1.25
Binocular rivalry requires visual attention. Neuron (2011) 1.25
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.23
fMRI-EEG integrated cortical source imaging by use of time-variant spatial constraints. Neuroimage (2007) 1.22
Single cell gene expression profiling in Alzheimer's disease. NeuroRx (2006) 1.22
Multi-excitation magnetoacoustic tomography with magnetic induction for bioimpedance imaging. IEEE Trans Med Imaging (2010) 1.22
A cortical potential imaging study from simultaneous extra- and intracranial electrical recordings by means of the finite element method. Neuroimage (2006) 1.21
3D current source density imaging based on the acoustoelectric effect: a simulation study using unipolar pulses. Phys Med Biol (2011) 1.20
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry (2002) 1.20
Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol (2011) 1.20